WASHINGTON, D.C. — Researchers have detected a link between alcohol consumption, cancer and aging that starts at the cellular level with telomere shortening.
Results of this cross-sectional study were presented at the American Association for Cancer Research 101st Annual Meeting 2010, held here, April 17-21, at the Walter E. Washington Convention Center.
Telomeres are found at the region of DNA sequences at the end of a chromosome, and are important for the genetic stability of cells. As people age, telomere length shortens progressively.
Excessive use of alcohol has been linked to oxidative stress and inflammation, two mechanisms that accelerate telomere shortening. Since telomere shortening is thought to increase cancer risk, the researchers speculated that those with shorter telomeres due to heavy alcohol consumption would have an increased risk of cancer.
“Heavy alcohol users tend to look haggard, and it is commonly thought heavy drinking leads to premature aging and earlier onset of diseases of aging. In particular, heavy alcohol drinking has been associated with cancer at multiple sites,” said lead researcher Andrea Baccarelli, M.D., Ph.D.
“All the cells in our body have a biological clock in telomeres,” noted Baccarelli, who is head of the Center of Molecular and Genetic Epidemiology, Ca’ Granda Hospital Foundation, University of Milan, Italy.
Using real-time polymerase chain reaction, the researchers measured serum DNA among 59 participants who abused alcohol (22 percent consumed four or more alcoholic drinks per day) and 197 participants with variable alcohol consumption habits (4 percent consumed four or more alcoholic drinks per day).
The two groups were similar in age and other factors that might affect telomere length, such as diet, physical exercise, work-related stress and environmental exposures.
Results showed that telomere length was dramatically shortened in those who consumed heavy amounts of alcohol; telomere length was nearly half as long as telomere length in the non-abusers (0.41 vs. 0.79 relative units).
Carriers of the variant genotype ADH1B were more likely to be abusers and had shorter telomere length, according to Baccarelli.
“The decrease we found in telomere length is very sharp, and we were surprised to find such a strong effect at the cellular level,” Baccarelli said.
Download interviews with cancer researchers and recordings of the teleconferences by subscribing to the AACR Scientific Podcasts via iTunes (http://www.aacr.org/itunes) or an RSS Reader (http://www.aacr.org/rss).
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 31,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowship and career development awards. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.
